effect doxazosin serum lipid review clinic data molecular basi alter lipid metabol goal antihypertens treatment reduct high blood pressur effect manag cholesterol level risk factor coronari heart diseas chd control clinic trial doxazosin antihypertens efficaci compar class antihypertens agent level total cholesterol low-dens lipoprotein ldl cholesterol triglycerid level high-dens lipoprotein cholesterol doxazosin develop chd front first doxazosin bind alpha receptor-medi respons second doxazosin direct indirect effect lipid metabol ldl receptor activ intracellular ldl synthesi synthesi secret low-dens lipoprotein cholesterol lipoprotein lipas activ doxazosin platelet aggreg long-term studi action reduct morbid mortal rate chd first-year result treatment mild hypertens studi tomh reduct blood pressur antihypertens agent lipid chang type antihypertens treatment favor doxazosin 